The Role Of Improved Pre-Transfusion Testing In The Prevention Of Delayed Serologic Transfusion Reactions Among Blood Recipients In Uganda: A Randomized Controlled Trial (IPAT Study)

Simple item page
dc.contributor.authorNatukunda, Bernard
dc.contributor.authorNdeezi, Grace
dc.contributor.authorEr, Lay See
dc.contributor.authorBajunirwe, Francis
dc.contributor.authorTeramura, Gayle
dc.contributor.authorDelaney, Meghan
dc.date.accessioned2022-01-24T19:20:47Z
dc.date.available2022-01-24T19:20:47Z
dc.date.issued2019
dc.description.abstractThe goal of pre-transfusion testing (PTT) is to provide patients with beneficial and safe transfusions. In Uganda, PTT includes ABO/RhD typing plus room temperature (RT) saline cross-matches without red-blood-cell (RBC) alloantibody screening. The aim of the IPAT study was to assess the role of improved PTT in the prevention of delayed serologic transfusion reactions (DSTRs).In this randomized controlled trial, patients at Mbarara Hospital in Uganda, with a history of RBC exposure, were randomized 1:1 to have either RBC alloantibody screening (SCREEN group) or room temperature saline cross-matches (CONTROL group) during PTT. ‘Home-made’ reagent RBCs from group O RhD-positive volunteers were used for antibody screening in the indirect antiglobulin test. Participants were evaluated for RBC alloantibody production 7–14 days after transfusion. Post-transfusion haemoglobin estimation and direct antiglobulin tests (DATs) were also performed.We randomized 220 patients to either the SCREEN or CONTROL group. Both study arms had similar demographic and transfusion characteristics at baseline. There were 19 (17·3%) individuals in the CONTROL group with DSTRs compared to 8 (7·3%) in the SCREEN group at the time of follow-up (P = 0·02). Overall, post-transfusion DATs were positive in 7 (3·5%) patients but there was no associated decrease in haemoglobin levels.Red-blood-cell alloantibody screening is associated with occurrence of significantly fewer DSTRs. The use of ‘home-made’ reagent cells during PTT in Uganda is feasible. We recommend a change in the local PTT policy to consider the introduction of RBC alloantibody screening.en_US
dc.identifier.citationNatukunda, B., Ndeezi, G., See Er, L., Bajunirwe, F., Teramura, G., & Delaney, M. (2019). The role of improved pre‐transfusion testing in the prevention of delayed serologic transfusion reactions among blood recipients in Uganda: a Randomized Controlled Trial (IPAT Study). ISBT Science Series, 14(4), 366-373.https://doi.org/10.1111/voxs.12493en_US
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/1516
dc.language.isoenen_US
dc.publisherISBT Science Seriesen_US
dc.subjectblood transfusion, delayed serologic transfusion reactions, pre-transfusion testing, RBC alloantibody screening, Ugandaen_US
dc.titleThe Role Of Improved Pre-Transfusion Testing In The Prevention Of Delayed Serologic Transfusion Reactions Among Blood Recipients In Uganda: A Randomized Controlled Trial (IPAT Study)en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
The Role Of Improved Pre-Transfusion Testing In The.pdf
Size:
169.24 KB
Format:
Adobe Portable Document Format
Description:
The Role Of Improved Pre-Transfusion Testing In The Prevention Of Delayed Serologic Transfusion Reactions Among Blood Recipients In Uganda: A Randomized Controlled Trial (IPAT Study)
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences